The Top 4 Infertility Myths — and What the Science Actually Says
Infertility affects approximately one in six people of reproductive age globally, according to the World Health Organization. And yet the information landscape around fertility — when conception is possible, what causes infertility, what treatment actually offers, and what options exist beyond IVF — remains remarkably distorted by myths that circulate as confidently as facts.
These myths matter not just because they lead to misinformed decisions, but because they carry emotional weight. The belief that infertility is primarily a female failure, or that IVF is a guarantee, shapes how people experience one of the most vulnerable and significant chapters of their reproductive lives. Getting the facts right is the foundation of informed, compassionate care — whether you are navigating this personally, or supporting someone who is.
The reality is that fertility is a shared biological system, that its challenges arise from a complex range of factors, and that outcomes are influenced by science and individual biology rather than by effort or deservingness.
Myth 1: Conception Is Only Possible on One Specific Day Each Month
The idea that there is a single "magic day" each month when pregnancy can occur — typically pinpointed to the day of ovulation — is one of the most pervasive misconceptions in reproductive health, and one of the most consequential.
The reality is more nuanced. The fertile window in a menstrual cycle spans approximately five to six days: the day of ovulation itself, and the several days leading up to it. This extended window exists because sperm can survive in the female reproductive tract for up to five days under optimal conditions, meaning intercourse that occurs several days before ovulation can still result in fertilization when the egg is released.
Ovulation timing is also far more variable than the textbook "day 14" framework suggests. While that estimate applies to women with a textbook 28-day cycle, cycle length varies considerably between individuals — and even within the same person from month to month. Stress, illness, travel, changes in sleep, and other factors can shift ovulation timing significantly. Relying on a fixed calendar date without any attention to individual cycle patterns is therefore an unreliable strategy.
For women who want to optimize timing, ovulation predictor kits that detect the luteinizing hormone (LH) surge — which typically precedes ovulation by 24 to 36 hours — offer a more personalized and reliable signal than calendar counting alone. Basal body temperature tracking and cervical mucus observation are additional methods that, used together, can provide a more complete picture of individual fertile window timing.
The practical implication: if you have been told conception is only possible on one specific day, or if you have been timing intercourse too rigidly around a fixed calendar date, you may be missing your actual fertile window. Regular intercourse every one to two days throughout the presumed fertile window is a reasonable and often more effective approach than attempting precision timing around a single target date.
Myth 2: Infertility Is Primarily a Female Problem
This may be the most damaging myth in the infertility space, because it directs investigation, blame, and emotional burden almost exclusively toward women — even when the cause of a couple's difficulty conceiving lies elsewhere entirely.
The data is clear and has been consistent for decades: male-factor infertility contributes to approximately 40 to 50 percent of all infertility cases. In roughly one-third of cases, male factors are the primary or sole identified cause. In another third, both male and female factors are present. Only in the remaining third are female factors the primary contributor.
Male-factor infertility encompasses a range of conditions: low sperm count (oligospermia), absent sperm in the ejaculate (azoospermia), poor sperm motility (the ability of sperm to move effectively), and abnormal sperm morphology (shape and structure). All of these are identifiable through a semen analysis — a relatively simple, non-invasive test that should be among the first steps in any fertility workup, regardless of whether the female partner has also had preliminary evaluation.
Secondary infertility — difficulty conceiving after a previous successful pregnancy — is a particularly striking context in which this myth plays out. Many couples who conceive their first child without difficulty assume that subsequent difficulty must have a new cause on the female side, and defer or avoid male-factor evaluation as a result. In reality, secondary infertility warrants the same bilateral evaluation as primary infertility, and male factors are implicated in a significant proportion of these cases.
The practical implication: if you are navigating fertility challenges, both partners should be evaluated simultaneously, from the beginning. A semen analysis is a reasonable first step alongside initial female evaluation — not something to pursue only after female investigation is complete.
Myth 3: IVF Guarantees Pregnancy
In vitro fertilization has transformed reproductive medicine over the past four decades and made biological parenthood possible for millions of people who would otherwise have had no path to it. It is a genuinely remarkable technology. It is not a guarantee.
IVF success rates vary significantly — and understanding that variation is essential for setting realistic expectations before undertaking what is a physically, emotionally, and often financially demanding process.
The single most significant predictor of IVF success is the age of the egg — which correlates with the age of the woman contributing the eggs, or the age of the egg donor if donor eggs are used. The American Society for Reproductive Medicine's most recent published data shows that for women under 35 using their own eggs, the percentage of IVF cycles that result in a live birth is typically in the 40 to 50 percent range per cycle — meaning that even in the most favorable demographic, a given cycle does not succeed more often than it does. For women over 40 using their own eggs, success rates per cycle drop considerably.
Additional factors that affect IVF outcomes include the underlying cause of infertility, prior pregnancy history, ovarian reserve (assessed through tests like anti-Müllerian hormone levels and antral follicle count), and the number and quality of embryos available for transfer. A couple's individual predicted success rate is always more meaningful than population-level statistics, and a reproductive endocrinologist can use validated models to help predict individual outcomes based on specific clinical parameters.
What IVF does offer is the most comprehensive supported reproductive technology currently available — including the ability to preimplant embryos for chromosomal screening, which reduces the risk of miscarriage and failed implantation from chromosomal abnormality. But that capability does not translate into a guarantee.
The practical implication: IVF is a powerful tool, not a certainty. Decisions about pursuing it should be grounded in realistic, individualized success rate projections — not in the assumption that if you undergo IVF, a baby will follow.
Myth 4: IVF Is the Only Treatment for Infertility
IVF occupies so much of the public conversation about infertility treatment that many people arrive at fertility clinics assuming it is either the first step or the only meaningful option. Neither is accurate.
A wide range of treatments exist that are appropriate for specific causes of infertility — and for many patients, these options are effective, less invasive, and significantly less expensive than IVF.
Ovulation induction with oral medications such as clomiphene citrate or letrozole is an effective first-line treatment for women with ovulatory dysfunction, including those with polycystic ovarian syndrome (now renamed polyendocrine metabolic ovarian syndrome, or PMOS). Intrauterine insemination (IUI) — which involves placing prepared sperm directly into the uterine cavity at the time of ovulation — is appropriate for certain causes of infertility including mild male-factor issues, unexplained infertility, and some cervical factors. Surgical interventions can address structural causes such as uterine fibroids, polyps, or blocked fallopian tubes. Treatment of the underlying male-factor cause — through urology referral — can restore fertility potential without any female-side intervention at all.
IVF is most clearly indicated when simpler interventions have not succeeded, when bilateral tubal obstruction is present, when severe male-factor infertility requires intracytoplasmic sperm injection (ICSI), or when preimplantation genetic testing is a priority. It is also used for non-infertility purposes, including fertility preservation before chemotherapy, radiation, or other gonadotoxic treatments, and for individuals or couples who need egg or sperm donation.
The practical implication: the appropriate treatment for infertility depends entirely on its cause — which is why diagnosis-first is the most important principle in fertility care. A thorough workup should precede any treatment recommendation, and the recommendation that emerges should be the most appropriate for the identified diagnosis, not the most technologically advanced option available.
A Final Word on Removing the Blame
The myths covered here share a common feature: they tend to concentrate uncertainty, responsibility, and inadequacy on women — around timing (did you do it right?), causation (is this your fault?), and treatment outcomes (why didn't it work?). The reality is that fertility is a shared biological system, that its challenges arise from a complex range of factors, and that outcomes are influenced by science and individual biology rather than by effort or deservingness.
If you are navigating infertility, you deserve accurate information, bilateral evaluation from the start, and a clinical team that treats this as the medical issue it is rather than a reflection of anything you have or haven't done.
Defy Menopause - Own the Change
Many women tell me: "One day I feel amazing. The next, I can barely get out of bed. Is this normal?"
Yes, it is. And no, you don’t have to suffer through it alone.
Hormonal fluctuations during perimenopause can make you feel like you’ve lost control of your body. But knowledge is powerful. And there are clear, science-backed ways to support your hormones, ease symptoms, and reclaim your energy.
That’s exactly why I created Defy Menopause: Own the Change — a 30-day program designed to give you the tools, knowledge, and support you need to move through these changes with clarity and confidence.
Inside, you’ll find:
Access to Dr. Tracy Verrico at one (1) live, group session
Clear action steps for managing symptoms naturally
Because you deserve more than just "putting up with it."
You deserve to thrive.
Let’s Connect
Schedule an Appointment | LinkedIn | YouTube | Instagram | Bona Dea Gynecology
Medical Disclaimer: The information provided in this blog is for general educational and informational purposes only and is not intended as, nor should it be considered, medical advice. This content does not establish a physician-patient relationship and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read in this newsletter. If you think you may have a medical emergency, call your doctor or emergency services immediately.
References
World Health Organization. Infertility Prevalence Estimates, 1990-2021. WHO; 2023. who.int
American Society for Reproductive Medicine. Infertility: An Overview. asrm.org
Gnoth C, Godehardt E, Frank-Herrmann P, Friol K, Tigges J, Freundl G. Definition and prevalence of subfertility and infertility. Hum Reprod. 2005;20(5):1144-1147.
Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation. N Engl J Med. 1995;333(23):1517-1521.
Isaksson R, Tiitinen A. Present concept of unexplained infertility. Gynecol Endocrinol. 2004;18(5):278-290.
Thonneau P, Marchand S, Tallec A, et al. Incidence and main causes of infertility in a resident population of three French regions. Hum Reprod. 1991;6(6):811-816.
Centers for Disease Control and Prevention. ART Success Rates. cdc.gov/art
Zegers-Hochschild F, Adamson GD, Dyer S, et al. The International Glossary on Infertility and Fertility Care. Fertil Steril. 2017;108(3):393-406.
